GPT and metabolic syndrome: In a final set of models (unadjusted and adjusted for covariates), we explored the contribution of MetS to CHD mortality using prevalent MetS as the referent group (Table 5) and found a positive association between CHD mortality and elevated biomarker ratio with MetS (elevated UACR: HR = 2.03, 1.28–3.22, and elevated AST-ALT: HR = 3.20, 1.86–5.51).